BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29243245)

  • 1. Treatment deintensification in human papillomavirus-positive oropharynx cancer: Outcomes from the National Cancer Data Base.
    Cheraghlou S; Yu PK; Otremba MD; Park HS; Bhatia A; Zogg CK; Mehra S; Yarbrough WG; Judson BL
    Cancer; 2018 Feb; 124(4):717-726. PubMed ID: 29243245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
    Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of American Joint Committee on Cancer Eighth Edition clinical stage and smoking history on oncologic outcomes in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Hawkins PG; Mierzwa ML; Bellile E; Jackson WC; Malloy KM; Chinn SB; Spector ME; Shuman AG; Stucken CL; McLean SA; Bradford CR; Prince ME; Carey TE; Worden FP; Swiecicki PL; Taylor JMG; Wolf GT; Eisbruch A; Casper KA
    Head Neck; 2019 Apr; 41(4):857-864. PubMed ID: 30775826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
    Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
    Cramer JD; Ferris RL; Kim S; Duvvuri U
    Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
    O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
    J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Smoking in Human Papillomavirus-Positive Oropharyngeal Cancer Under American Joint Committee on Cancer Eighth Edition Stage.
    Chidambaram S; Nakken ER; Kennedy W; Thorstad WL; Chen SY; Pipkorn P; Zevallos JP; Mazul AL
    Laryngoscope; 2020 Aug; 130(8):1961-1966. PubMed ID: 32293733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of concomitant chemoradiotherapy in AJCC 7
    Lu DJ; Luu M; Nguyen AT; Shiao SL; Scher K; Mita A; Anderson E; Clair JM; Ho AS; Zumsteg ZS
    Oral Oncol; 2020 Nov; 110():104882. PubMed ID: 32650257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
    Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
    Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mature results of a prospective study of deintensified chemoradiotherapy for low-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Chera BS; Amdur RJ; Tepper JE; Tan X; Weiss J; Grilley-Olson JE; Hayes DN; Zanation A; Hackman TG; Patel S; Sheets N; Weissler MC; Mendenhall WM
    Cancer; 2018 Jun; 124(11):2347-2354. PubMed ID: 29579339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma.
    Sher DJ; Rusthoven CG; Khan SA; Fidler MJ; Zhu H; Koshy M
    Cancer; 2017 Jan; 123(2):273-282. PubMed ID: 27649421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the Eighth Edition American Joint Committee on Cancer Staging System for HPV-Related Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
    Badhey AK; Olson A; Kadakia S; Russo J; Ting P; Khalid M; Yao M; Teng MS; Genden EM; Miles BA; Chai RL
    Laryngoscope; 2018 May; 128(5):1133-1139. PubMed ID: 28990700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.
    Owadally W; Hurt C; Timmins H; Parsons E; Townsend S; Patterson J; Hutcheson K; Powell N; Beasley M; Palaniappan N; Robinson M; Jones TM; Evans M
    BMC Cancer; 2015 Aug; 15():602. PubMed ID: 26311526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It is not just IMRT: Human papillomavirus related oropharynx squamous cell carcinoma is associated with better swallowing outcomes after definitive chemoradiotherapy.
    Naik M; Ward MC; Bledsoe TJ; Kumar AM; Rybicki LA; Saxton JP; Burkey BB; Greskovich JF; Adelstein DJ; Koyfman SA
    Oral Oncol; 2015 Aug; 51(8):800-4. PubMed ID: 25977228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.